Dian Diagnostics Group: Controlling shareholder releases 28.5166 mln shares from pledge

NBD AI Bulletin,Dian Diagnostics Group Co., Ltd. (the Company, SZ 300244, closing price: 34.8 yuan) announced on the evening of July 1 that the Company's controlling shareholder Chen Haibin released about 28.5166 million shares previously pledged to CITIC Construction Investment Securities Co., Ltd., accounting for 14.74% of his holdings. His person acting in concert, Hangzhou Dian Holdings Co., Ltd., released 1.72 million shares, representing 12.25% of its holdings, that were previously pledged to Haitong Securities Co., Ltd. A total of 30.24 million shares were released from pledge.

According to the 2019 annual report, Dian Diagnostics Group Co., Ltd.'s main businesses are commerce and service, accounting for 65.09% and 34.91% of revenue, respectively.

Dian Diagnostics Group Co., Ltd. is chaired by Chen Haibin, male, 51 years old, Chinese national, no permanent residence abroad, EMBA from China Europe International Business School. Dian Diagnostics Group Co., Ltd.'s general manager is Huang Baixing, male, 64 years old, Malaysian national, with permanent residence in China.

(By Li Menglin)

Disclaimer: This article is for informational purposes only and does Not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.